跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
泰圣奇 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Atezolizumab Injection
Approved
生物制品
Atezolizumab Injection
Roche Registration GmbH
🇨🇳 National Medical Products Administration
Approval Date
Feb 11, 2020
Approval ID
7uclAdwwBnI
Company
Roche Registration GmbH
Type
生物制品
Approval Details
Approval Id
7uclAdwwBnI
Approval Number
S20200004
Generic Name
阿替利珠单抗注射液
Generic Name En
Atezolizumab Injection
Trade Name
泰圣奇
Drug Type
生物制品
Dosage Form
注射剂
Strength
1200mg/20ml(60mg/ml)
Reg Date
2020-02-11
Expired Date
2025-02-10
Company Name
Roche Registration GmbH
Company Address
Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Germany
Production Company Name
roche diagnostics gmbh; f. hoffmann-la roche ltd
Production Company Address
Sandhofer Strasse 116, 68305 Mannheim, Germany; Wurmisweg, 4303 Kaiseraugst, Switzerland
Company Detail Path
/organization/roche-registration-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 11, 2020
Approval ID
7uclAdwwBnI
Type
生物制品
Back to NMPA Approvals